About Us Technology Malaria Investors News / Events Contact Us Home

Every day malaria causes 3,000 deaths and one million clinical episodes

41% of the human race lives in areas of high malaria transmission

More than half a billion people are infected with malaria each year

Artepharm has developed a fast, inexpensive and effective treatment

Artepharm’s treatment eliminated deaths due to malaria on the Island of Moheli

Artepharm Global Corp. is currently marketing Artequick®, a natural artemisinin-based anti-malaria drug that uses a western pharmaceutical delivery system, developed by Artepharm Co., a Chinese company. This patented and proprietary treatment has been an effective, inexpensive and fastest acting anti-malaria drug (see Dateline's video about Artepharm Co.)

Artequick Treatment

Artequick has been approved for sale by the China State Food and Drug Administration and in 12 countries where malaria is endemic. By acquiring the patent and the worldwide marketing rights from Artepharm Co., Artepharm Global Corp.’s goal is the complete eradication of malaria worldwide.

News Video

Artequick® significantly reduced incidences and eliminated deaths due to malaria on the Island of Moheli in the Comoros – where there was a 22% malaria mortality rate.

Dateline News Video

Click here to view.

News Releases

July 16, 2010 Reuters Reports That Artepharm Global's Artequick Eradicates Malaria on the East Africa Island of Moheli MORE...

July 13, 2010 Artepharm Global Corp.: World Health Organisation Reports Half the Worlds Population Is at Risk of Malaria MORE...